Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Shire study highlights impact of ADHD on children

Shire study highlights impact of ADHD on children

2nd June 2011

Shire has published data from a new European survey that highlights the impact attention deficit hyperactivity disorder (ADHD) can have on the lives of children.

The pharmaceutical company provided funding to support the European Lifetime Impairment Survey, which was conducted in six nations, including the UK, and involved more than 2,500 respondents.

It found that paediatric patients with ADHD are more likely to miss days of school and suffer from poor academic performance, while they also find it more difficult to get on with siblings or have a healthy social life.

The study also noted that despite these issues, it takes parents of children with ADHD an average of 26.8 months to achieve a diagnosis of the condition.

Myriam Menter of ADHD Europe said this "highlights the need for better access to ADHD services to get the best package of care for every child and help avoid some of these consequences".

According to Shire's most recent financial report, the company saw increased demand for its ADHD therapies in the first quarter of 2011, including Vyvanse, Intuniv and Adderall XR.ADNFCR-8000103-ID-800564768-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.